Risk Assessment
The purpose of risk assessment is estimation of the severity of harmful effects to human health and the environment that may result from exposure to chemicals present in the environment. The Environmental Protection Agency (EPA) procedure of risk assessment, whether related to human health or to the environment, involves four steps: 1. hazard assessment 2. dose–response assessment 3. exposure assessment 4. risk characterization The quantity of chemicals in use today is staggering. According to the data compiled by Hodgson and Guthrie in 1980 (1), there were then 1500 active ingredients of pesticides, 4000 active ingredients of therapeutic drugs, 2000 drug additives to improve stability, 2500 food additives with nutritional value, 3000 food additives to promote product life, and 50,000 additional chemicals in common use. Considering the growth of the chemical and pharmaceutical industries, these amounts must now be considerably larger. Past experience has shown that some of these chemicals, although not toxic unless ingested in large quantities, may be mutagenic and carcinogenic with chronic exposure to minute doses, or may interfere with the reproductive or immune systems of humans and animals. To protect human health it is necessary to determine that compounds to which people are exposed daily or periodically in their daily lives (such as cosmetics, foods, and pesticides) will not cause harm upon long-term exposure. The discussion in this chapter will focus primarly on carcinogenicity and mutagenicity, but also endocrine disrupters will be considered. The carcinogenicity of some chemicals was established through epidemiological studies. However, because of the long latency period of cancer, epidemiological studies require many years before any conclusions can be reached. In addition, they are very expensive. Another method that could be used is bioassay in animals. Such bioassays, although quite useful in predicting human cancer hazard, may take as long as 2 years or more and require at least 600 animals per assay. This method is also too costly in terms of time and money to be considered for large-scale screening. For these reasons an inexpensive, short-term assay system is needed for preliminary evaluation of potential mutagens and carcinogens.